$2.34
3.08%
Nasdaq, Oct 02, 04:00 pm EDT. Closed.
ISIN
US04962H5063
Symbol
ATOS

Atossa Genetics Inc. Target price 2026 - Analyst rating & recommendation

Atossa Genetics Inc. Classifications & Recommendation

Buy
88%
Hold
13%

Atossa Genetics Inc. Price Target

Target Price $22.44
Price $2.34
Potential
Number of Estimates 5
5 Analysts have issued a price target Atossa Genetics Inc. 2027 . The average Atossa Genetics Inc. target price is $22.44. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 8 analysts: 7 Analysts recommend Atossa Genetics Inc. to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Atossa Genetics Inc. stock has an average upside potential 2027 of . Most analysts recommend the Atossa Genetics Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ -4.04 -4.03
32.89% 0.25%
P/E negative

5 Analysts have issued a Atossa Genetics Inc. forecast for earnings per share. The average Atossa Genetics Inc. EPS is

$-4.03
unlock
. This is
4.73% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$-3.66 13.48%
unlock
, the lowest is
$-4.32 2.13%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-4.04 32.89%
2026
$-4.03 0.25%
unlock
2027
$-2.63 34.74%
unlock
2028
$2.96 212.55%
unlock
2029
$-0.15 105.07%
unlock
2030
$-0.09 40.00%
unlock

P/E ratio

Current -0.55 85.82%
2026
-0.58 4.84%
unlock
2027
-0.89 53.45%
unlock
2028
0.79 188.76%
unlock

Current Atossa Genetics Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Ascendiant Capital
Locked
➜
Locked
Locked Oct 01 2026
Rodman & Renshaw
Locked
➜
Locked
Locked Jul 07 2026
Ascendiant Capital
Locked
➜
Locked
Locked Apr 10 2026
HC Wainwright & Co.
Locked
➜
Locked
Locked Mar 26 2026
Ascendiant Capital
Locked
➜
Locked
Locked Dec 08 2025
Ascendiant Capital
Locked
➜
Locked
Locked Sep 22 2025
Ascendiant Capital
Locked
➜
Locked
Locked Jun 06 2025
Analyst Rating Date
Locked
Ascendiant Capital:
Locked
➜
Locked
Oct 01 2026
Locked
Rodman & Renshaw:
Locked
➜
Locked
Jul 07 2026
Locked
Ascendiant Capital:
Locked
➜
Locked
Apr 10 2026
Locked
HC Wainwright & Co.:
Locked
➜
Locked
Mar 26 2026
Locked
Ascendiant Capital:
Locked
➜
Locked
Dec 08 2025
Locked
Ascendiant Capital:
Locked
➜
Locked
Sep 22 2025
Locked
Ascendiant Capital:
Locked
➜
Locked
Jun 06 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today